Not Yet Recruiting
Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia
NCT07538713
- Conditions
- CAR T Cell Therapy, CD33 Positive Acute Myelogenous Leukemia
- Locations
-
Not specified